Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Market Attractiveness

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Antibody Drug Conjugates Market - Key Industry Dynamics

4.1 Key Market Drivers:

4.1.1 Growing Strategic Partnerships to Develop Antibody Drug Conjugates

4.1.2 Rising Incidences of Cancer Cases

4.1.3 Increasing FDA Approvals for ADCs

4.2 Market Restraints

4.2.1 High Cost of ADCs Development and Commercialization

4.3 Market Opportunities

4.3.1 Increasing Investments to Develop ADCs

4.4 Market Trends

4.4.1 Escalating Pipeline of ADCs

4.5 Impact Analysis:

5. Antibody Drug Conjugates Market - North America Market Analysis

5.1 North America Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030

6. North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Technology

6.1 Overview

6.2 North America Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)

6.3 Cleavable Linker

6.3.1 Overview

6.3.2 Cleavable Linker: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Non-cleavable Linker

6.4.1 Overview

6.4.2 Non-cleavable Linker: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 North America Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Blood Cancer

7.3.1 Overview

7.3.2 Blood Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Breast Cancer

7.4.1 Overview

7.4.2 Breast Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Ovarian Cancer

7.5.1 Overview

7.5.2 Ovarian Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Urothelial Cancer

7.6.1 Overview

7.6.2 Urothelial Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 North America Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

8.3 Hospital Pharmacies

8.3.1 Overview

8.3.2 Hospital Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Retail Pharmacies

8.4.1 Overview

8.4.2 Retail Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Online Pharmacies

8.5.1 Overview

8.5.2 Online Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Drug Conjugates Market - Country Analysis

9.1 North America Antibody Drug Conjugates Market, Revenue and Forecast To 2030

9.1.1 Overview

9.1.2 North America Antibody Drug Conjugates Market Breakdown, by Country Revenue (2022) (US$ Million)

9.1.3 North America: Antibody Drug Conjugates Market, by Countries,2022 and 2030 (%)

9.1.3.1 US

9.1.3.1.1 Overview

9.1.3.1.2 US: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.1.3 US: Antibody Drug Conjugates Market, by Technology

9.1.3.1.4 US: Antibody Drug Conjugates Market, by Application

9.1.3.1.5 US: Antibody Drug Conjugates Market, by Distribution Channel

9.1.3.2 Canada

9.1.3.2.1 Overview

9.1.3.2.2 Canada: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.2.3 Canada: Antibody Drug Conjugates Market, by Technology

9.1.3.2.4 Canada: Antibody Drug Conjugates Market, by Application

9.1.3.2.5 Canada: Antibody Drug Conjugates Market, by Distribution Channel

9.1.3.3 Mexico

9.1.3.3.1 Overview

9.1.3.3.2 Mexico: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.3.3 Mexico: Antibody Drug Conjugates Market, by Technology

9.1.3.3.4 Mexico: Antibody Drug Conjugates Market, by Application

9.1.3.3.5 Mexico: Antibody Drug Conjugates Market, by Distribution Channel

10. Antibody Drug Conjugates Market-Industry Landscape

10.1 Overview

10.2 Organic Growth Strategies

10.2.1 Overview

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Companies' Manufacturing Capacities and Capabilities

11. Company Profiles

11.1 ADC Therapeutics SA

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Pfizer Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Hoffmann-La Roche Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 ImmunoGen, Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 GSK Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Gilead Sciences Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 AstraZeneca Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Astellas Pharma Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 RemeGen Co Ltd

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Takeda Pharmaceutical Co Ltd

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. North America Antibody Drug Conjugates Market Segmentation

Table 2. New Cancer Cases Worldwide, in 2020

Table 3. List of FDA-Approved ADCs

Table 4. US: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 5. US: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 6. US: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 7. Canada: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 8. Canada: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 9. Canada: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 10. Mexico: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 11. Mexico: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 12. Mexico: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 13. Recent Organic Growth Strategies in Antibody Drug Conjugates Market

Table 14. Recent Inorganic Growth Strategies in the Antibody Drug Conjugates Market

Table 15. Glossary of Terms, Antibody Drug Conjugates Market

List of Figures

Figure 1. North America Antibody Drug Conjugates Market Segmentation, By Country

Figure 2. Key Insights

Figure 3. North America Antibody Drug Conjugates Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. North America Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030

Figure 6. North America Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 7. Cleavable Linker: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Cleavable Linker: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)

Figure 10. Blood Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Breast Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Ovarian Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Urothelial Cancer: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. North America Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

Figure 16. Hospital Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Retail Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Online Pharmacies: North America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. North America Antibody Drug Conjugates, by Key Country - Revenue (2022) (US$ Million)

Figure 20. North America: Antibody Drug Conjugates Market, By Key Countries, 2022 and 2030 (%)

Figure 21. US: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. Canada: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Mexico: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)